These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation. Dzobo KE; Cupido AJ; Mol BM; Stiekema LCA; Versloot M; Winkelmeijer M; Peter J; Pennekamp AM; Havik SR; Vaz FM; van Weeghel M; Prange KHM; Levels JHM; de Winther MPJ; Tsimikas S; Groen AK; Stroes ESG; de Kleijn DPV; Kroon J Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):720-740. PubMed ID: 38269588 [TBL] [Abstract][Full Text] [Related]
8. Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a). Yeang C; Hung MY; Byun YS; Clopton P; Yang X; Witztum JL; Tsimikas S J Clin Lipidol; 2016; 10(3):594-603. PubMed ID: 27206947 [TBL] [Abstract][Full Text] [Related]
9. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. Bergmark C; Dewan A; Orsoni A; Merki E; Miller ER; Shin MJ; Binder CJ; Hörkkö S; Krauss RM; Chapman MJ; Witztum JL; Tsimikas S J Lipid Res; 2008 Oct; 49(10):2230-9. PubMed ID: 18594118 [TBL] [Abstract][Full Text] [Related]
10. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Tsimikas S; Tsironis LD; Tselepis AD Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2094-9. PubMed ID: 17626905 [TBL] [Abstract][Full Text] [Related]
11. Associations between lipoprotein(a), oxidized phospholipids, and extracoronary vascular disease. Bellomo TR; Liu Y; Gilliland TC; Miksenas H; Haidermota S; Wong M; Hu X; Cristino JR; Browne A; Plutzky J; Tsimikas S; Januzzi JL; Natarajan P J Lipid Res; 2024 Jul; 65(7):100585. PubMed ID: 38942114 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281 [TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice. Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084 [TBL] [Abstract][Full Text] [Related]